In tumors, EVI5 expression is dysregulated in multiple cancer types, such as non–small-cell lung cancer, laryngeal cancer, and hepatocellular carcinoma, and EVI5 is therefore considered potential oncogenes and cell-cycle regulators25–27. This evidence concerns the gene EVI5 and hepatocellular carcinoma.